Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHA:600721)
8.92
-0.18 (-1.98%)
Apr 17, 2026, 3:00 PM CST
SHA:600721 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 298.65 | 272.05 | 202.07 | 135.73 | 86.88 |
Cash & Short-Term Investments | 298.65 | 272.05 | 202.07 | 135.73 | 86.88 |
Cash Growth | 9.78% | 34.63% | 48.88% | 56.22% | 56.22% |
Accounts Receivable | 229.06 | 202.04 | 217.65 | 204.24 | 167.04 |
Other Receivables | 5.03 | 6.45 | 6.18 | 3.95 | 7.94 |
Receivables | 234.09 | 208.48 | 223.82 | 208.19 | 174.98 |
Inventory | 30.36 | 99.72 | 124.83 | 149.43 | 194.05 |
Other Current Assets | 2.31 | 3.02 | 14.04 | 12.32 | 12.18 |
Total Current Assets | 565.41 | 583.27 | 564.77 | 505.67 | 468.09 |
Property, Plant & Equipment | 138.27 | 140.11 | 138.19 | 147.8 | 161.64 |
Long-Term Investments | 55.15 | 63.77 | 63.7 | 60.74 | 58.51 |
Goodwill | 11.49 | 11.49 | 11.49 | 11.49 | 11.49 |
Other Intangible Assets | 6.59 | 8.41 | 10.07 | 11.49 | 11.67 |
Long-Term Deferred Tax Assets | 34.84 | 31.78 | 14.82 | 15.4 | 14.94 |
Long-Term Deferred Charges | 37.13 | 30.19 | 13.47 | 4.17 | 4.68 |
Other Long-Term Assets | 248.69 | 245.53 | 245.51 | 244.93 | 251.29 |
Total Assets | 1,098 | 1,115 | 1,062 | 1,002 | 982.31 |
Accounts Payable | 56.81 | 86.65 | 100.73 | 92.82 | 58.39 |
Accrued Expenses | 26.57 | 29.57 | 29.15 | 26.8 | 25.18 |
Short-Term Debt | - | - | - | - | 6.3 |
Current Portion of Leases | - | 0.1 | 0.44 | 0.51 | - |
Current Income Taxes Payable | 2.08 | 1.78 | 1.45 | 1.22 | 1.17 |
Current Unearned Revenue | 110.13 | 140.51 | 111.27 | 98.85 | 85.73 |
Other Current Liabilities | 51.25 | 50.51 | 65.4 | 69 | 77.11 |
Total Current Liabilities | 246.84 | 309.12 | 308.44 | 289.2 | 253.89 |
Long-Term Leases | - | - | 1.13 | 1.82 | - |
Long-Term Unearned Revenue | 1.3 | 1.06 | 1.81 | 2.35 | 3.02 |
Pension & Post-Retirement Benefits | 0.96 | 1.16 | 0.83 | 0.99 | 0.88 |
Long-Term Deferred Tax Liabilities | 45.47 | 43.52 | 42.09 | 39.8 | 36.88 |
Other Long-Term Liabilities | 1.16 | 1.1 | 1.1 | 0.5 | 1.39 |
Total Liabilities | 295.73 | 355.96 | 355.39 | 334.66 | 296.06 |
Common Stock | 384.55 | 384.03 | 381.69 | 377.67 | 375.13 |
Additional Paid-In Capital | 362.34 | 2,266 | 2,258 | 2,235 | 2,217 |
Retained Earnings | 47.72 | -1,898 | -1,940 | -1,953 | -1,918 |
Comprehensive Income & Other | 7.24 | 7.2 | 7.29 | 7.43 | 7.66 |
Total Common Equity | 801.84 | 758.58 | 706.62 | 667.01 | 681.3 |
Minority Interest | - | - | - | - | 4.95 |
Shareholders' Equity | 801.84 | 758.58 | 706.62 | 667.01 | 686.25 |
Total Liabilities & Equity | 1,098 | 1,115 | 1,062 | 1,002 | 982.31 |
Total Debt | - | 0.1 | 1.57 | 2.33 | 6.3 |
Net Cash (Debt) | 298.65 | 271.95 | 200.5 | 133.4 | 80.59 |
Net Cash Growth | 9.82% | 35.64% | 50.29% | 65.54% | 44.90% |
Net Cash Per Share | 0.78 | 0.71 | 0.53 | 0.35 | 0.21 |
Filing Date Shares Outstanding | 384.55 | 384.03 | 381.69 | 377.67 | 375.13 |
Total Common Shares Outstanding | 384.55 | 384.03 | 381.69 | 377.67 | 375.13 |
Working Capital | 318.57 | 274.15 | 256.33 | 216.47 | 214.21 |
Book Value Per Share | 2.09 | 1.98 | 1.85 | 1.77 | 1.82 |
Tangible Book Value | 783.76 | 738.68 | 685.06 | 644.04 | 658.14 |
Tangible Book Value Per Share | 2.04 | 1.92 | 1.79 | 1.71 | 1.75 |
Buildings | 161.92 | 161.92 | 161.92 | 161.73 | 158.52 |
Machinery | 185.39 | 174.08 | 158.62 | 150.41 | 146.97 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.